ReNeuron Group plc
Company Profile
Company website
Sector
Pharmaceuticals and Biotechnology (Biotechnology)
Description
ReNeuron has developed a proprietary stem cell-derived, exosome-based, drug delivery platform with customisable cellular targeting capabilities for the delivery of complex drug modalities.
Investor Access
25
May
Event information
The company will release its preliminary results for the year ended 31 March 2023 on Thursday 25 May 2023.
Venue
Online
Time
Thursday 25 May 2023 at 9:30am
Financial Calendar
| Event | Date |
| Year End | 31 March |
| Half Year End | 30 September |
| Preliminary Results* | July |
| Interim Results* | December |
| AGM* | September |
* Months based on previous announcements of this kind
